Skip to main content

MoneyWorks4Me

Divi’s Laboratories informs about schedule of analyst meeting

18 Nov 2019 Evaluate

Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Divi’s Laboratories has informed about schedule of meeting of Analyst(s)/ Investor(s) on 21st & 25th November 2019 at Hyderabad.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1764.60
Dr. Reddys Labs. 1355.10
Cipla 1378.30
Lupin 2023.30
Zydus Lifesciences 1238.00
View more..